Form 4: Amylyx Pharmaceuticals Executive Receives Stock Grant
Insider Transaction (Form 4)
Gina Mazzariello, Chief Legal Officer of Amylyx Pharmaceuticals, Inc., received 21,284 shares of common stock on August 18, 2026.
Summary
- Grant/award: acquired 21,284 Common Stock on August 18, 2026; holds 200,374 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Gina Mazzariello — Officer (Chief Legal Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-18 | Grant/award | Common Stock | 21,284 | — | — | 200,374 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-18 | Grant/award (21,284 shares) |
Keywords
insider transaction, Form 4, AMLX, Amylyx Pharmaceuticals, Inc., neutral, Gina Mazzariello
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.